Pharmacovigilance Guidance Document for the Marketing Authorization Holders (MAHs)
The comments on this draft should be reached with valid justification within 30 days from the date of uploading by 22/02/2024 to This email address is being protected from spambots. You need JavaScript enabled to view it.